Rick Wise
Stock Analyst at Stifel Nicolaus
(0.49)
# 4,094
Out of 4,468 analysts
805
Total ratings
46.5%
Success rate
-2.1%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintained: Buy | $75 → $65 | $45.14 | +44.00% | 66 | Jun 25, 2026 | |
| MDT Medtronic | Maintained: Hold | $95 → $80 | $83.19 | -3.83% | 50 | Jun 3, 2026 | |
| AORT Artivion | Maintained: Buy | $45 | $23.97 | +87.73% | 20 | Jun 1, 2026 | |
| HTFL HeartFlow | Maintained: Buy | $40 | $27.97 | +43.04% | 5 | May 15, 2026 | |
| BDX Becton, Dickinson and Company | Maintained: Buy | $215 → $175 | $158.08 | +10.70% | 31 | May 8, 2026 | |
| LMAT LeMaitre Vascular | Maintained: Buy | $115 → $120 | $102.88 | +16.64% | 24 | May 8, 2026 | |
| TSX: PRN Profound Medical Corp. | Rated: Buy | $17.06 → $14.22 | $9.75 | +45.83% | 10 | May 8, 2026 | |
| OM Outset Medical | Rated: Buy | $8 → $6 | $4.72 | +27.12% | 30 | May 8, 2026 | |
| MDLN Medline | Maintained: Buy | $55 → $50 | $43.19 | +15.77% | 3 | May 8, 2026 | |
| ATRC AtriCure | Maintained: Buy | $50 | $31.79 | +57.28% | 34 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $105 → $90 | $78.27 | +14.99% | 11 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $19 | $22.65 | -16.11% | 36 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $440 → $360 | $326.54 | +10.25% | 34 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $19.95 | +10.28% | 32 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $2.5 | $1.39 | +79.86% | 21 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $110 → $105 | $87.47 | +20.04% | 47 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $98 → $80 | $65.57 | +22.02% | 16 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $110 | $94.37 | +16.56% | 50 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $670 | $426.01 | +57.27% | 48 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $145 → $120 | $95.40 | +25.79% | 44 | Apr 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $220 → $250 | $263.04 | -4.96% | 30 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $26.98 | +11.19% | 7 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 | $4.21 | -28.74% | 24 | Mar 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $80 | $83.62 | -4.33% | 36 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $14 | $24.93 | n/a | 32 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 | $33.83 | n/a | 32 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $0.0001 | n/a | 8 | Jun 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $25 → $30 | $2.30 | n/a | 13 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $34 | $15.32 | n/a | 9 | Aug 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $557.80 | n/a | 2 | Nov 8, 2012 |
Boston Scientific
Jun 25, 2026
Maintained: Buy
Price Target: $75 → $65
Current: $45.14
Upside: +44.00%
Medtronic
Jun 3, 2026
Maintained: Hold
Price Target: $95 → $80
Current: $83.19
Upside: -3.83%
Artivion
Jun 1, 2026
Maintained: Buy
Price Target: $45
Current: $23.97
Upside: +87.73%
HeartFlow
May 15, 2026
Maintained: Buy
Price Target: $40
Current: $27.97
Upside: +43.04%
Becton, Dickinson and Company
May 8, 2026
Maintained: Buy
Price Target: $215 → $175
Current: $158.08
Upside: +10.70%
LeMaitre Vascular
May 8, 2026
Maintained: Buy
Price Target: $115 → $120
Current: $102.88
Upside: +16.64%
Profound Medical Corp.
May 8, 2026
Rated: Buy
Price Target: $17.06 → $14.22
Current: $9.75
Upside: +45.83%
Outset Medical
May 8, 2026
Rated: Buy
Price Target: $8 → $6
Current: $4.72
Upside: +27.12%
Medline
May 8, 2026
Maintained: Buy
Price Target: $55 → $50
Current: $43.19
Upside: +15.77%
AtriCure
May 6, 2026
Maintained: Buy
Price Target: $50
Current: $31.79
Upside: +57.28%
May 6, 2026
Maintained: Buy
Price Target: $105 → $90
Current: $78.27
Upside: +14.99%
May 1, 2026
Maintained: Hold
Price Target: $20 → $19
Current: $22.65
Upside: -16.11%
May 1, 2026
Maintained: Buy
Price Target: $440 → $360
Current: $326.54
Upside: +10.25%
May 1, 2026
Reiterated: Buy
Price Target: $22
Current: $19.95
Upside: +10.28%
Apr 30, 2026
Maintained: Buy
Price Target: $5 → $2.5
Current: $1.39
Upside: +79.86%
Apr 29, 2026
Rated: Buy
Price Target: $110 → $105
Current: $87.47
Upside: +20.04%
Apr 29, 2026
Maintained: Buy
Price Target: $98 → $80
Current: $65.57
Upside: +22.02%
Apr 24, 2026
Maintained: Buy
Price Target: $110
Current: $94.37
Upside: +16.56%
Apr 22, 2026
Maintained: Buy
Price Target: $670
Current: $426.01
Upside: +57.27%
Apr 17, 2026
Rated: Buy
Price Target: $145 → $120
Current: $95.40
Upside: +25.79%
Apr 15, 2026
Rated: Hold
Price Target: $220 → $250
Current: $263.04
Upside: -4.96%
Mar 18, 2026
Maintained: Buy
Price Target: $30
Current: $26.98
Upside: +11.19%
Mar 1, 2026
Maintained: Hold
Price Target: $3
Current: $4.21
Upside: -28.74%
Feb 25, 2026
Reiterated: Buy
Price Target: $70 → $80
Current: $83.62
Upside: -4.33%
May 7, 2025
Maintained: Hold
Price Target: $17 → $14
Current: $24.93
Upside: n/a
May 1, 2025
Maintained: Hold
Price Target: $55
Current: $33.83
Upside: n/a
Jun 3, 2023
Maintained: Hold
Price Target: $1
Current: $0.0001
Upside: n/a
Feb 25, 2019
Upgraded: Buy
Price Target: $25 → $30
Current: $2.30
Upside: n/a
Aug 22, 2018
Maintained: Hold
Price Target: $25 → $34
Current: $15.32
Upside: n/a
Nov 8, 2012
Rated: Hold
Price Target: n/a
Current: $557.80
Upside: n/a